The gene editing treatment targets the relatively common 1717-1G>A splicing mutation, which does not respond to many current CF therapies.
A novel chemo-enzymatic approach to making synthetic 100-unit oligonucleotide single guide RNA (sgRNA) increases both purity and yield, according to its developers at F. Hoffmann-La Roche and ...
This article and associated images are based on a poster originally authored by Donato Tedesco, Tianbing Liu, Dongfang Hu, Nadya Isachenko, Debbie Deng, Paul Diehl and Alex Chenchik and presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results